Co-ordinates Stage I and II clinical trials based on the use of new drugs (kinase inhibitors, anti-angiogenic drugs, epigenetic modulators and monoclonal antibodies) for the treatment of patients with lymphoproliferative syndromes with relapse or refractory to conventional treatments.
Since July he has been head of the Experimental Oncological Therapies Section of the Department of Oncology and Haematology of the Humanitas Cancer Center.
Previous experience
- 2006-2011 Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Director of the Stem Cell Processing Laboratory - 1999-2011 Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Speciality Doctor
Department of Oncological Medicine
